Skip to main content

FDA has accepted NDA for dermatological drug Deuruxolitinib: Sun Pharma

Sun Pharmaceutical Industries Ltd said that it had submitted an 8mg twice-daily regimen of deuruxolitinib for FDA review

from Companies https://ift.tt/XusH0bl
via IFTTT

Comments

Popular posts from this blog